Differential Enantiomer-Specific Signaling of Cannabidiol at CB<sub>1</sub> Receptors.

Bosquez-Berger, Taryn; Wilson, Sierra; Iliopoulos-Tsoutsouvas, Christos; Jiang, Shan; Wager-Miller, Jim; Nikas, Spyros P; Mackie, Ken P; Makriyannis, Alexandros; Straiker, Alex

Differential Enantiomer-Specific Signaling of Cannabidiol at CB₁ Receptors.

Bosquez-Berger, Taryn; Wilson, Sierra; Iliopoulos-Tsoutsouvas, Christos; Jiang, Shan; Wager-Miller, Jim; Nikas, Spyros P; Mackie, Ken P; Makriyannis, Alexandros; Straiker, Alex.

Afiliação

Bosquez-Berger T; Gill Center for Biomolecular Science, Department of Psychological and Brain Sciences, Program in Neuroscience, Indiana University, Bloomington, Indiana (T.B., S.W., J.W.M., K.M., A.S.); and Center for Drug Discovery and Department of Pharmaceutical Sciences (C.I.T., S.P.N., A.M.) and Center for Drug
Wilson S; Gill Center for Biomolecular Science, Department of Psychological and Brain Sciences, Program in Neuroscience, Indiana University, Bloomington, Indiana (T.B., S.W., J.W.M., K.M., A.S.); and Center for Drug Discovery and Department of Pharmaceutical Sciences (C.I.T., S.P.N., A.M.) and Center for Drug
Iliopoulos-Tsoutsouvas C; Gill Center for Biomolecular Science, Department of Psychological and Brain Sciences, Program in Neuroscience, Indiana University, Bloomington, Indiana (T.B., S.W., J.W.M., K.M., A.S.); and Center for Drug Discovery and Department of Pharmaceutical Sciences (C.I.T., S.P.N., A.M.) and Center for Drug
Jiang S; Gill Center for Biomolecular Science, Department of Psychological and Brain Sciences, Program in Neuroscience, Indiana University, Bloomington, Indiana (T.B., S.W., J.W.M., K.M., A.S.); and Center for Drug Discovery and Department of Pharmaceutical Sciences (C.I.T., S.P.N., A.M.) and Center for Drug
Wager-Miller J; Gill Center for Biomolecular Science, Department of Psychological and Brain Sciences, Program in Neuroscience, Indiana University, Bloomington, Indiana (T.B., S.W., J.W.M., K.M., A.S.); and Center for Drug Discovery and Department of Pharmaceutical Sciences (C.I.T., S.P.N., A.M.) and Center for Drug
Nikas SP; Gill Center for Biomolecular Science, Department of Psychological and Brain Sciences, Program in Neuroscience, Indiana University, Bloomington, Indiana (T.B., S.W., J.W.M., K.M., A.S.); and Center for Drug Discovery and Department of Pharmaceutical Sciences (C.I.T., S.P.N., A.M.) and Center for Drug
Mackie KP; Gill Center for Biomolecular Science, Department of Psychological and Brain Sciences, Program in Neuroscience, Indiana University, Bloomington, Indiana (T.B., S.W., J.W.M., K.M., A.S.); and Center for Drug Discovery and Department of Pharmaceutical Sciences (C.I.T., S.P.N., A.M.) and Center for Drug
Makriyannis A; Gill Center for Biomolecular Science, Department of Psychological and Brain Sciences, Program in Neuroscience, Indiana University, Bloomington, Indiana (T.B., S.W., J.W.M., K.M., A.S.); and Center for Drug Discovery and Department of Pharmaceutical Sciences (C.I.T., S.P.N., A.M.) and Center for Drug
Straiker A; Gill Center for Biomolecular Science, Department of Psychological and Brain Sciences, Program in Neuroscience, Indiana University, Bloomington, Indiana (T.B., S.W., J.W.M., K.M., A.S.); and Center for Drug Discovery and Department of Pharmaceutical Sciences (C.I.T., S.P.N., A.M.) and Center for Drug

Mol Pharmacol ; 102(6): 259-268, 2022 Dec.

Article em En | MEDLINE | ID: mdl-36153039

Assuntos

Canabidiol; Canabidiol/farmacologia; Dronabinol/farmacologia; Agonistas de Receptores de Canabinoides/farmacologia; Endocanabinoides; Transdução de Sinais; Receptor CB1 de Canabinoide; Receptor CB2 de Canabinoide

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Canabidiol Idioma: En Revista: Mol Pharmacol Ano de publicação: 2022 Tipo de documento: Article